We currently do not have sufficient information about the CEO.
Key information
Chenyu Liang
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
less than a year
CEO ownership
n/a
Management average tenure
less than a year
Board average tenure
less than a year
Recent management updates
No updates
Recent updates
CEO
Chenyu Liang
less than a year
Tenure
Mr. Chenyu Liang is CEO & Director of Cellyan Biotechnology Co., Ltd (formerly known as Hong Kong Pharma Digital Technology Holdings Limited) from October 6, 2025. Mr. Liang’s experience spans several indu...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Chenyu Liang
CEO & Director
less than a year
no data
no data
Shu Liu
Chief Financial Officer
less than a year
no data
no data
Zifeng Wang
Chief Strategy Officer
less than a year
no data
no data
0.6yrs
Average Tenure
Experienced Management: HKPD's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Board Members
Name
Position
Tenure
Compensation
Ownership
Chenyu Liang
CEO & Director
less than a year
no data
no data
Mike Yao Zhou
Independent Director
less than a year
no data
no data
Jingyan Wu
Independent Director
less than a year
no data
no data
Sun Wong Lap
Chairman of the Board
2.8yrs
US$89.82k
0.079% $ 9.8k
Leung Chan Kam
Independent Director
no data
no data
no data
0.6yrs
Average Tenure
52yo
Average Age
Experienced Board: HKPD's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/26 20:42
End of Day Share Price
2026/05/22 00:00
Earnings
2025/09/30
Annual Earnings
2025/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cellyan Biotechnology Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.